Early detection is critical in the fight against cancer. Research is ongoing, and one of the most promising developments is the use of artificial intelligence to identify cancer in its early stages. These AI-driven techniques include AI-powered medical imaging, AI-enhanced liquid biopsies, predictive analytics in patient data, and AI in genomics.
SwissCognitive Guest Blogger: Zachary Amos – “4 Most Promising AI Techniques for Early Cancer Detection”
Early detection is critical in the fight against cancer. The sooner it is found, the greater the chance of survival, since it has likely not had a chance to spread, and less aggressive treatments can be deployed. Research is ongoing, and one of the most promising developments is the use of artificial intelligence to identify cancer in its early stages.
AI has become a present-day reality in health care and can find patterns beyond human perception. Here are four promising AI-driven techniques that are setting a new standard in early cancer diagnosis.
1. AI-Powered Medical Imaging
AI algorithms that employ deep learning models are trained to analyze medical images like mammograms, CT scans and MRIs. They can detect subtle anomalies and find cancerous nodules and lesions that may be missed by the human eye in the early stages. The algorithms can help reduce false negative rates and speed up the review process, as every second counts in a cancer diagnosis.
One study found that AI had a 45% accuracy rate in identifying lung cancer nodules under 1 cm in size, while human radiologists were only 25% accurate. Another study, which reviewed six studies covering lung nodules and breast lesions, discovered that AI either matched or exceeded radiologists’ detection rates. In one case, an AI model achieved a cancer discovery rate of 6.1 versus 5.1 for radiologists per 1,000 cases, resulting in a 44% workload reduction.
2. AI-Enhanced Liquid Biopsies
Liquid biopsies are minimally invasive medical tests that detect circulating tumor DNA (ctDNA) and other cancerous biomarkers in blood or bodily fluids. They can provide a comprehensive picture of the cancer’s genetic makeup by analyzing material shed into the bloodstream from different parts of the tumor.
AI is helping weed through the massive volume of data these tests provide to identify biomarkers that signify early-stage cancer. It is promising in decoding information from exosomes, which are released by cells and carry molecular messages to other cells. Cancer causes an excess of proteins, genetic material, metabolites and lipids in these exosomes that mirror what is happening inside the tumor. One study found that AI significantly improved the accuracy and clinical utility of liquid biopsies in gastrointestinal cancers by enabling high-throughput biomarker discovery and predictive modeling.
3. Predictive Analytics in Patient Data
AI is being used to analyze electronic health records (EHRs) and other large datasets to identify people at high risk of developing cancer. Doing so allows doctors to recommend earlier and more personalized screening schedules, leading to swifter identification of tumors.
One study found that combining the abilities of AI with the expertise of radiologists can achieve a 95% accuracy rate in the early detection of cancer. Additionally, a deep learning algorithm developed to predict the risk of pancreatic cancer detected the disease three years before actual diagnosis. AI and predictive analytics are proving to be a vital combination in the fight against cancer.
4. AI in Genomics
AI is accelerating the analysis of genomic and proteomic data (multi-omics), which combines information from DNA, RNA, proteins and other sources, to provide a holistic understanding of biological systems. Identifying specific genetic markers and protein interactions enables AI to predict someone’s lifetime risk of developing certain cancers.
Stanford Medicine created an AI-powered program using data from over 7,000 tumor samples to predict gene activity within cancerous cells. The team found it could use biopsy images to predict genetic variations in breast cancers and forecast patient outcomes. The information gathered could guide treatment without the need for costly genomic tests. Another deep-learning tool can predict the potential for disease in all possible variants in the human genome, leading to easier identification and earlier detection.
The Path Forward
These developments are exciting, but some practical hurdles stand in the way of widespread adoption. Cancer research funding has been placed under the microscope. Questions have arisen regarding the need to allocate more funds to early detection and prevention, rather than solely focusing on preclinical trials. These studies have received $18 billion, or 73.5%, of U.S. research funding allocations, and can take up to 17 years to see practical use. Conversely, only a small proportion of research investment is directed toward early detection.
This financial reality shows there’s a clear need for a more strategic use of AI in health care. Leadership and targeted investment are essential to turn its technological promise into tangible clinical benefits.
Harnessing the Power of AI in Early Detection
AI is proving to be a powerful tool in early cancer detection. It promises to revolutionize the health care industry and offers hope to patients worldwide. Funding should be allocated to further develop and strategically implement these technologies. Together, human expertise and AI can provide hope where it is so desperately needed.
About the Author:
Zac Amos is the Features Editor at ReHack, where he writes about artificial intelligence, cybersecurity and other tech topics.
Early detection is critical in the fight against cancer. Research is ongoing, and one of the most promising developments is the use of artificial intelligence to identify cancer in its early stages. These AI-driven techniques include AI-powered medical imaging, AI-enhanced liquid biopsies, predictive analytics in patient data, and AI in genomics.
SwissCognitive Guest Blogger: Zachary Amos – “4 Most Promising AI Techniques for Early Cancer Detection”
AI has become a present-day reality in health care and can find patterns beyond human perception. Here are four promising AI-driven techniques that are setting a new standard in early cancer diagnosis.
1. AI-Powered Medical Imaging
AI algorithms that employ deep learning models are trained to analyze medical images like mammograms, CT scans and MRIs. They can detect subtle anomalies and find cancerous nodules and lesions that may be missed by the human eye in the early stages. The algorithms can help reduce false negative rates and speed up the review process, as every second counts in a cancer diagnosis.
One study found that AI had a 45% accuracy rate in identifying lung cancer nodules under 1 cm in size, while human radiologists were only 25% accurate. Another study, which reviewed six studies covering lung nodules and breast lesions, discovered that AI either matched or exceeded radiologists’ detection rates. In one case, an AI model achieved a cancer discovery rate of 6.1 versus 5.1 for radiologists per 1,000 cases, resulting in a 44% workload reduction.
2. AI-Enhanced Liquid Biopsies
Liquid biopsies are minimally invasive medical tests that detect circulating tumor DNA (ctDNA) and other cancerous biomarkers in blood or bodily fluids. They can provide a comprehensive picture of the cancer’s genetic makeup by analyzing material shed into the bloodstream from different parts of the tumor.
AI is helping weed through the massive volume of data these tests provide to identify biomarkers that signify early-stage cancer. It is promising in decoding information from exosomes, which are released by cells and carry molecular messages to other cells. Cancer causes an excess of proteins, genetic material, metabolites and lipids in these exosomes that mirror what is happening inside the tumor. One study found that AI significantly improved the accuracy and clinical utility of liquid biopsies in gastrointestinal cancers by enabling high-throughput biomarker discovery and predictive modeling.
3. Predictive Analytics in Patient Data
AI is being used to analyze electronic health records (EHRs) and other large datasets to identify people at high risk of developing cancer. Doing so allows doctors to recommend earlier and more personalized screening schedules, leading to swifter identification of tumors.
One study found that combining the abilities of AI with the expertise of radiologists can achieve a 95% accuracy rate in the early detection of cancer. Additionally, a deep learning algorithm developed to predict the risk of pancreatic cancer detected the disease three years before actual diagnosis. AI and predictive analytics are proving to be a vital combination in the fight against cancer.
4. AI in Genomics
AI is accelerating the analysis of genomic and proteomic data (multi-omics), which combines information from DNA, RNA, proteins and other sources, to provide a holistic understanding of biological systems. Identifying specific genetic markers and protein interactions enables AI to predict someone’s lifetime risk of developing certain cancers.
Stanford Medicine created an AI-powered program using data from over 7,000 tumor samples to predict gene activity within cancerous cells. The team found it could use biopsy images to predict genetic variations in breast cancers and forecast patient outcomes. The information gathered could guide treatment without the need for costly genomic tests. Another deep-learning tool can predict the potential for disease in all possible variants in the human genome, leading to easier identification and earlier detection.
The Path Forward
These developments are exciting, but some practical hurdles stand in the way of widespread adoption. Cancer research funding has been placed under the microscope. Questions have arisen regarding the need to allocate more funds to early detection and prevention, rather than solely focusing on preclinical trials. These studies have received $18 billion, or 73.5%, of U.S. research funding allocations, and can take up to 17 years to see practical use. Conversely, only a small proportion of research investment is directed toward early detection.
This financial reality shows there’s a clear need for a more strategic use of AI in health care. Leadership and targeted investment are essential to turn its technological promise into tangible clinical benefits.
Harnessing the Power of AI in Early Detection
AI is proving to be a powerful tool in early cancer detection. It promises to revolutionize the health care industry and offers hope to patients worldwide. Funding should be allocated to further develop and strategically implement these technologies. Together, human expertise and AI can provide hope where it is so desperately needed.
About the Author:
Share this: